Skip to main content
. 2022 Oct 12;17(1):74. doi: 10.5334/gh.1157

Table 4.

Determinants of ideal CVH.


BIVARIATE MODELS MULTIVARIABLE MODELS


COR (95% CI) p-VALUE AOR (95% CI) p-VALUE

Age 0.97 (0.95–0.98) <0.001 0.96 (0.95–0.97) <0.001

Sex
Female
Male
Ref.
0.84 (0.53–1.35)
0.48

Level of education
Primary education
Secondary education
Beyond secondary
No school attended
Ref.
1.32 (0.78–2.23)
0.83 (0.28–2.42)
0.76 (0.29–1.98)
0.31
0.73
0.58

Occupation status
Self-employed
Retired or unemployed
Employed
Ref.
0.63 (0.42–0.96)
0.81 (0.68–0.97)
0.03
0.02
Ref.
0.59 (0.43–0.81)
0.76 (0.62–0.94)
<0.01
0.01

Relationship status
Married/cohabiting
Single/never married
Widowed
Ref.
1.28 (1.08–1.53)
0.94 (0.73–1.21)
0.01
0.66
Ref.
1.07 (0.91–1.27)
1.03 (0.85–1.25)
0.41
0.71

Insurance status
No
Yes
Ref.
0.66 (0.37–1.17)
0.16 Ref
0.85 (0.44–1.66)
0.64

ART regimen
TDF+3TC+DTG (TLD)
Other
Ref.
0.76 (0.43–1.36)
0.36

HIV viral load
≤50
>50
Ref.
1.10 (0.76–1.60)
0.61

Years lived with HIV infection 1.02 (1.00–1.04) 0.11 1.02 (0.98–1.06) 0.27

Duration of ART (years) 1.02 (1.01–1.05) 0.09 1.01 (0.98–1.05) 0.37

Adherence to ART
Good adherence
Poor adherence
Ref.
0.97 (0.56–1.68)
0.92

Alcohol use
No
Yes
Ref.
0.16 (0.24–0.85)
0.01 Ref.
0.41 (0.21–0.80)
0.01

Presence of comorbidities
No
Yes
Ref.
0.65 (0.47–0.92)
0.01 Ref.
0.68 (0.48–0.97)
0.04

NCD Medication use (HTN, diabetes, dyslipidemia) (n,%)
No
Yes
Ref.
0.84 (0.50–1.42)
0.53

Lifestyle modification (n,%)
No
Yes
Ref.
0.92 (0.60–1.40)
0.71

Family history of CVD (n,%)
No
Yes
Ref.
1.05 (0.64–1.71)
0.84

Lifestyle modification to control hypertension, diabetes, hyperlipidemia, obesity, obesity, smoking, diet and increase physical activity.

Comorbidities include self-reports of myocardial infraction (heart attacks), stroke, hypertension, diabetes or hyperlipidemia.